FNIP1 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL23804991	1.00	1/20
SCHEMBL23817956	0.72	1/20
SCHEMBL23817957	0.72	1/20
SCHEMBL23817934	0.70	1/20
SCHEMBL25171623	0.68	1/20
SCHEMBL23804993	0.67	1/20
SCHEMBL23817969	0.67	1/20
SCHEMBL25455689	0.64	1/20
SCHEMBL23817980	0.62	1/20
SCHEMBL30132888	0.62	1/20
SCHEMBL23818008	0.62	1/20
SCHEMBL31562917	0.62	1/20
SCHEMBL20456266	0.61	1/20
SCHEMBL23804989	0.61	1/20
SCHEMBL23817966	0.61	1/20
SCHEMBL30132890	0.61	1/20
SCHEMBL23817999	0.60	1/20
SCHEMBL23818422	0.60	1/20
SCHEMBL25455734	0.60	1/20
SCHEMBL31074337	0.60	1/20

Clinical trials — most relevant to FNIP1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma	PHASE4	UNKNOWN
Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies	PHASE4	COMPLETED
Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men	PHASE3	ACTIVE_NOT_RECRUITING
Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia	nan	COMPLETED
Investigation of Copy Number Variations and Genetic Variants in POI	nan	RECRUITING
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)	nan	UNKNOWN
IVM for Patients With Low Ovarian Response. Does it Improve IVFoutcomes and Does it Improve the Following IVF Cycle?	nan	UNKNOWN
Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer	nan	ACTIVE_NOT_RECRUITING
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer	nan	COMPLETED
IVF Outcome in Polycystic Ovary Syndrome Patients	nan	UNKNOWN
Proteomics & Glyco-Proteomic Analysis of Follicular Fluid	nan	UNKNOWN
Human MATER and Idiopathic Infertility	nan	COMPLETED
Genetic Analysis of Fraser Syndrome and Fryns Syndrome	nan	COMPLETED
Assessment of Candidate Protein Expression in Breast Cancer Specimens	nan	COMPLETED
A Post Marketing Assessment of Gonal f Solution for Injection in a Prefilled Pen for Follicular Stimulation in in Vitro Fertilisation/Embryo Transfer (IVF-ET) Cycles	nan	COMPLETED
CircularRNA-microRNA-mRNA Regulatory Axis in IVF	nan	NOT_YET_RECRUITING
Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity	nan	COMPLETED
Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease	nan	COMPLETED
Role of Vaspin in Pathophysiology of Pre-eclampsia	nan	UNKNOWN
Family Blood Pressure Program - GenNet Network	nan	COMPLETED
Prospective Genetic Study in Patients With Ovarian Insufficiency	nan	UNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA	nan	RECRUITING
Pheno- & Genotyping POF (WHO III)	nan	UNKNOWN
Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)	nan	RECRUITING
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism	nan	COMPLETED
Analysis of Toxins in Follicle Fluid	nan	COMPLETED
Integrated Model for Promoting Parenting and Early School Readiness in Pediatrics	nan	COMPLETED
Premature Ovarian Failure (Genetic and Physiopathologic Analysis)	nan	UNKNOWN
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a FNIP1 binder may also engage these)

Protein	Name	Similarity
Q68FD7	—	1.000	Q68FD7 →
Q5W4S4	—	0.998	Q5W4S4 →
Q80TD3	—	0.995	Q80TD3 →
Q9P278	—	0.993	Q9P278 →
Q5ZI58	—	0.984	Q5ZI58 →
Q9Y4F3	—	0.983	Q9Y4F3 →
E1BZ85	—	0.982	E1BZ85 →
Q32MH5	—	0.982	Q32MH5 →
Q6NRE4	—	0.982	Q6NRE4 →
Q9H706	—	0.981	Q9H706 →
E7FA21	—	0.981	E7FA21 →
Q99ME3	—	0.981	Q99ME3 →
Q8IVF5	—	0.981	Q8IVF5 →
Q7TP65	—	0.981	Q7TP65 →
Q69ZK7	—	0.981	Q69ZK7 →
Q3UMB5	—	0.980	Q3UMB5 →
Q7Z4H7	—	0.980	Q7Z4H7 →
Q6GVH5	—	0.980	Q6GVH5 →
Q6GPJ8	—	0.980	Q6GPJ8 →
Q8TEV9	—	0.980	Q8TEV9 →
Q8VIG2	—	0.980	Q8VIG2 →
Q3UFT3	—	0.980	Q3UFT3 →
Q501R9	—	0.980	Q501R9 →
Q8WW38	—	0.980	Q8WW38 →
Q95JY0	—	0.979	Q95JY0 →
P97432	—	0.979	P97432 →
Q5SV77	—	0.979	Q5SV77 →
Q80Y19	—	0.979	Q80Y19 →
Q9NWN3	—	0.979	Q9NWN3 →
Q6ZPF3	—	0.979	Q6ZPF3 →